Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 12:58PM ET
9.07
Dollar change
-0.48
Percentage change
-5.03
%
Index- P/E- EPS (ttm)-1.24 Insider Own14.09% Shs Outstand9.95M Perf Week5.22%
Market Cap90.25M Forward P/E- EPS next Y-0.93 Insider Trans0.00% Shs Float8.55M Perf Month51.17%
Income-12.36M PEG- EPS next Q0.26 Inst Own28.37% Short Float0.26% Perf Quarter65.73%
Sales0.00M P/S- EPS this Y81.52% Inst Trans- Short Ratio0.34 Perf Half Y150.55%
Book/sh1.01 P/B8.94 EPS next Y-6.02% ROA-117.95% Short Interest0.02M Perf Year121.90%
Cash/sh1.09 P/C8.29 EPS next 5Y- ROE-522.52% 52W Range3.21 - 9.90 Perf YTD22.40%
Dividend Est.- P/FCF- EPS past 5Y- ROI-122.53% 52W High-8.38% Beta0.80
Dividend TTM- Quick Ratio6.54 Sales past 5Y0.00% Gross Margin- 52W Low182.55% ATR (14)0.61
Dividend Ex-Date- Current Ratio6.54 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)66.74 Volatility7.40% 7.56%
Employees6 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price13.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q17.19% Payout- Rel Volume1.15 Prev Close9.55
Sales Surprise- EPS Surprise3.46% Sales Q/Q- EarningsNov 08 BMO Avg Volume65.86K Price9.07
SMA2021.26% SMA5030.22% SMA20074.80% Trades Volume42,448 Change-5.03%
Today 08:15AM
Feb-22-24 08:15AM
Feb-21-24 08:15AM
Feb-13-24 08:15AM
Jan-29-24 08:15AM
08:15AM Loading…
Jan-18-24 08:15AM
Jan-16-24 08:15AM
03:59AM
Jan-05-24 08:00AM
Dec-20-23 08:30AM
Dec-14-23 03:54PM
03:54PM
Dec-13-23 08:00AM
Dec-12-23 08:00AM
Dec-06-23 07:05AM
07:00AM Loading…
07:00AM
Nov-08-23 09:00AM
Oct-27-23 09:00AM
Oct-09-23 08:00AM
Oct-05-23 09:00AM
Oct-03-23 09:00AM
Sep-27-23 09:00AM
Sep-22-23 09:00AM
Sep-07-23 09:15AM
Aug-31-23 08:00AM
Aug-25-23 09:00AM
Aug-21-23 01:31PM
07:00AM
Aug-08-23 07:00AM
Aug-03-23 07:00AM
07:00AM Loading…
Jul-19-23 07:00AM
Jul-17-23 12:21PM
07:00AM
Jul-05-23 08:30AM
Jun-28-23 07:00AM
Jun-20-23 07:00AM
Jun-14-23 07:00AM
Jun-12-23 07:00AM
Jun-07-23 07:00AM
Jun-05-23 07:00AM
May-22-23 07:00AM
May-16-23 02:42PM
08:50AM
07:00AM
May-12-23 07:47AM
May-10-23 07:00AM
May-09-23 07:15AM
07:00AM
May-02-23 03:30PM
Apr-14-23 09:00AM
Mar-31-23 07:00AM
Mar-29-23 04:01PM
09:00AM
Mar-27-23 07:00AM
Mar-23-23 09:15AM
07:44AM
Mar-22-23 09:15AM
Mar-21-23 11:38AM
11:24AM
09:55AM
07:50AM
07:00AM
Mar-20-23 07:00AM
Mar-09-23 07:00AM
Mar-06-23 09:00AM
Feb-28-23 09:00AM
Feb-27-23 07:00AM
Feb-16-23 09:15AM
Feb-15-23 07:13AM
Feb-02-23 09:00AM
Jan-26-23 09:01AM
Jan-03-23 04:15PM
Dec-29-22 11:20AM
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.